Not a good buy right now at $385: price is extended after a strong +7.3% regular-session move and sits close to near-term resistance (391–405), which compresses upside vs. downside.
Despite a bullish technical trend, insider and hedge-fund selling are strong negatives that argue against chasing at current levels.
If you must act immediately (impatient entry), the risk/reward favors holding off rather than buying into resistance; a better buy zone would be closer to the pivot (~370) or on a clean breakout/close above ~391 with follow-through.
RSI(6) ~67.8: approaching overbought; upside may be limited short-term after the sharp jump.
Key levels: Pivot ~369.6 (first meaningful support area); Resistance R1 ~391.3 then R2 ~404.8.
Pattern-based odds suggest limited near-term edge: +1.31% next day, but -2% next week and -3.61% next month (momentum may fade).
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/skew: OI put/call 0.87 and volume put/call 0.32 lean bullish (more call interest/activity than puts).
Volatility: IV30 ~87.9 with IV percentile ~99.2 (options extremely expensive vs. recent history), often seen around peak excitement—can coincide with near-term topping/mean reversion.
Activity: Today’s volume (636) is below the 30D average (~74%), suggesting sentiment isn’t accelerating despite the price surge.
Technical Summary
Sell
4
Buy
7
Positive Catalysts
on 2026-03-05 after hours (Est. EPS ~1.99).
Neutral/Negative Catalysts
with RSI elevated; unfavorable immediate entry for an impatient buyer.
Financial Performance
Latest quarter: 2026/Q3.
Revenue: $251.15M, down -2.28% YoY (topline soft).
Profitability: Net income $30.74M, up +9.74% YoY; EPS $2.17, up +8.50% YoY.
Margins: Gross margin ~18.69%, up +8.35% YoY—earnings growth is being driven by margin expansion rather than revenue growth.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent direction: Mixed. Goldman initiated Buy with $397 PT (bullish theme exposure); GLJ upgraded to Buy with $369 PT; Lake Street downgraded to Hold with $325 PT (valuation/peak estimates concern).
Price vs. targets: Current ~385 is above GLJ’s $369 and well above Lake Street’s $325, and only slightly below Goldman’s $397—suggesting limited upside to the most bullish published PT while carrying meaningful downside to the more cautious view.
Wall Street pros: strong backlog visibility, margin execution, and secular gas generation buildout.
Wall Street cons: valuation looks stretched at current levels; expectations are high, making the stock vulnerable to any deceleration or guidance disappointment.
Wall Street analysts forecast AGX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AGX is 365.25 USD with a low forecast of 325 USD and a high forecast of 397 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast AGX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AGX is 365.25 USD with a low forecast of 325 USD and a high forecast of 397 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 345.970
Low
325
Averages
365.25
High
397
Current: 345.970
Low
325
Averages
365.25
High
397
Lake Street
Buy
to
Hold
downgrade
$260 -> $325
AI Analysis
2025-12-05
Reason
Lake Street
Price Target
$260 -> $325
AI Analysis
2025-12-05
downgrade
Buy
to
Hold
Reason
Lake Street downgraded Argan to Hold from Buy with a price target of $325, up from $260. Argan is executing well with strong margins and a $3B backlog that provides visibility for the next two to three years, but shares are trading at a "top-tier valuation on peak estimates" that reflect strong execution, increased margins, and full activity on its current pipeline, the analyst tells investors.
GLJ Research
Hold
to
Buy
upgrade
$369
2025-11-10
Reason
GLJ Research
Price Target
$369
2025-11-10
upgrade
Hold
to
Buy
Reason
GLJ Research upgraded Argan to Buy from Hold with a $369 price target.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for AGX
